PAN-Biotech · PAN-Celltech · Case study

Securing supply after a supplier discontinuation

When an incumbent supplier discontinued an established RUO / for-further-manufacturing product, PAN-Biotech absorbed the whole transition end-to-end under PAN Complete - reproducing the product to specification, carrying its FDA product registration and delivering full customisation - and turned a supply-security emergency into a documented, secure supply.

Results at a glance
Supply secured · a documented, secure supply chain; product in supply FDA product registration · carried by PAN-Biotech for the transferred product End-to-end (PAN Complete) · registration, sourcing, production, QA/QC, logistics Full customisation · complete customised packaging reproduced to spec

This story is published with the customer anonymised. It describes a real PAN-Biotech engagement; the customer's name is withheld.

The context

An established product, an established supply

An established product owner relied on an RUO / for-further-manufacturing product that had a settled place in its own customers' workflows. The supply was routine - until it was not.

The challenge

When an incumbent supplier exits

The existing supplier discontinued the product, and the owner faced an urgent gap. They needed a new manufacturer who could reproduce the product to specification, carry an FDA product registration, and deliver full customisation - all within a short time frame, before the shortfall reached their own customers. A supplier exit had become a supply-security emergency.

The solution

One partner, end-to-end under PAN Complete

A single partner absorbed the whole transition end-to-end:

  • FDA product registration completed successfully for the transferred product.
  • A secure supply chain set up for the complete, customised packaging material.
  • Raw-material sourcing organised under one roof.
  • Production under validated processes, with full QA / QC documentation.
  • Labelling, packing, storage and on-demand shipping - the whole downstream chain.
The result

A crisis turned into secured supply

A supplier discontinuation is exactly the moment a company can least afford friction. Consolidating registration, sourcing, production, documentation and logistics with one qualified partner turned the crisis into a documented, secured supply - the supply-continuity case, delivered under pressure. The product is in supply, and the owner's own customers saw no interruption.

FAQ

Frequently asked questions

What can a company do when its supplier discontinues an RUO or for-further-manufacturing product?

Move the product to a partner who can reproduce it to specification, carry the necessary product registration and take on the full chain - sourcing, validated production, QA/QC documentation, custom packaging and logistics - so the transfer closes the gap before it reaches downstream customers.

Can PAN-Biotech carry the FDA product registration for a transferred product?

Yes. In this case PAN-Biotech completed the FDA product registration for the transferred product as part of an end-to-end PAN Complete transfer.

What does an end-to-end (PAN Complete) supply transfer include?

Product registration, raw-material sourcing, production under validated processes with full QA/QC documentation, customised packaging, and labelling, packing, storage and on-demand shipping - consolidated with one partner.

Facing a supplier exit or a second-source decision?

PAN-Biotech can take on a discontinued or at-risk product end-to-end - registration, sourcing, validated production, documentation and logistics - so your supply stays secure.

PAN-Biotech GmbH · RUO / for-further-manufacturing supply · Customer anonymised. Product registration and scope as described for the transferred product only.